Biosimilars Blog
Privacy Blog
RF EMerge Blog
RF 360


Insightful. Precise. Skilled.

Daniel Shores at NEHEN Virtual Meeting on the Future of Messenger mRNA Technology


April 5, 2021

On Monday, April 5, 2021, partner Daniel Shores will be a panelist during the New England Healthcare Executive Network (NEHEN) monthly meeting on "The Future of MRNA Technology: The Next Frontier in Therapeutics."

The development of a COVID-19 vaccine in 11 months to approval condensed decades of messenger RNA research and drug development. From the virus genetic code released in January 2020 scientists at mRNA-based companies quickly designed a vaccine. Beyond the COVID-19 vaccine breakthrough, mRNA offers a newly commercialized approach and therapeutic tool. This groundbreaking technology may open up a wide range of new therapies and markets for infectious disease and other indications for decades to come. Mr. Shores will join other industry leaders to discuss trends in mRNA technology, intellectual property, investments, and translation to breakthrough therapies. 

To learn more about the event, and to register, please click here.

Rothwell Figg is proud to be a 2021 sponsor of NEHEN.